Spironolactone

CAS 52-01-7 11 current records 8 historicalSmall Molecule

Who holds supplier records for Spironolactone? 11 organisations hold a current record for Spironolactone: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (6), France (1), Hungary (1), India (1) and 2 other countries (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Spironolactone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/spironolactone

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Spironolactone expires 28 Oct 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Spironolactone. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • EUROAPI FRANCE
    Active DMF 17264 · latest filing Mar 2004
    FranceCEP Company GMP cert on record
  • Gedeon Richter
    Active DMF 14077 · latest filing Mar 1999
    HungaryCEP Company GMP cert on record
  • TIANJIN TIANYAO PHARMACEUTICALS CO LTD
    Active DMF 18238 · latest filing Mar 2005
    ChinaCEP
  • Zhejiang Langhua Pharmaceutical Co. Ltd.
    Active DMF 26881 · latest filing Feb 2013
    ChinaCEP
  • Zhejiang Shenzhou Pharmaceutical Co., Ltd.
    Active DMF 20286 · latest filing Mar 2007
    ChinaCEP
  • DASAMI LAB PRIVATE LTD
    Active DMF 36678 · latest filing Feb 2022
    India Company GMP cert on record
  • HUBEI GOTO BIOTECHNOLOGY CO LTD
    Active DMF 32370 · latest filing May 2018
    China
  • NORTEC QUIMICA SA
    Active DMF 37708 · latest filing Jun 2024
    Brazil
  • Tianjin Jinjin Pharmaceuticals Co., Ltd.
    Active DMF 30192 · latest filing Dec 2015
    China
  • United StatesCEP
  • TIANJIN JINJIN PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Spironolactone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Spironolactone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG SHENZHOU PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2003-175 - Rev 06
Spironolactone, Micronised
Aug 2026—
TIANJIN JINJIN PHARMACEUTICAL CO., LTD. Xiqing DistrictCN
CEP 2012-185 - Rev 01
Spironolactone, Process B
Jun 2026—
EUROAPI FRANCE VertolayeFR
CEP 2000-167 - Rev 08
Spironolactone, Micronised
Jul 2025Inspected Jul 2025
France
G.D. Searle LLC New YorkUS
CEP 1997-038 - Rev 07
Spironolactone
Mar 2024—
TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. TianjinCN
R1-CEP 2011-291 - Rev 01
Spironolactone, TY II
Feb 2022—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 2000-005 - Rev 05
Spironolactone, Micronised
Jul 2019—
ZHEJIANG LANGHUA PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2004-203 - Rev 01
Spironolactone
May 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Spironolactone are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • United Kingdom · Inactive DMF 25496 · filed Jan 2012
  • ZHEJIANG XINHUA PHARMACEUTICAL CO LTD
    Inactive DMF 19859 · filed Oct 2006
  • Italy · Inactive DMF 18546 · filed Jul 2005
  • BOEHRINGER MANNHEIM GMBH
    Inactive DMF 3350 · filed Oct 1978
  • SCHERING AG
    Inactive DMF 3332 · filed Oct 1978
  • MEDIMPEX NORTHAMERICA INC
    Inactive DMF 3343 · filed Sept 1978
  • Italy · Inactive DMF 3052 · filed Oct 1977
  • Brazil · Inactive DMF 2657 · filed Apr 1976

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (36 listed products contain Spironolactone). The latest listed patent expires 28 Oct 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Spironolactone is a potassium-sparing diuretic that is used to reduce fluid retention and treat high blood pressure. It works as an aldosterone antagonist, blocking the effect of aldosterone and aiding in the excretion of sodium and water from the body.

Chemical identity

IUPAC name
S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate
Canonical SMILES
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C
InChIKey
LXMSZDCAJNLERA-FYQPLNBISA-N
Synonyms
Aldactone API

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Aldosterone Antagonist
Mechanism of action
Aldosterone Antagonists

Therapeutic areas

CardiologyEndocrinologyNephrology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Spironolactone?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Spironolactone: EUROAPI FRANCE (France), Gedeon Richter (Hungary), TIANJIN TIANYAO PHARMACEUTICALS CO LTD (China), Zhejiang Langhua Pharmaceutical Co. Ltd. (China), Zhejiang Shenzhou Pharmaceutical Co., Ltd. (China), DASAMI LAB PRIVATE LTD (India), HUBEI GOTO BIOTECHNOLOGY CO LTD (China) and NORTEC QUIMICA SA (Brazil), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Spironolactone Drug Master Files are active?

EUROAPI FRANCE (DMF 17264), Gedeon Richter (DMF 14077), TIANJIN TIANYAO PHARMACEUTICALS CO LTD (DMF 18238), Zhejiang Langhua Pharmaceutical Co. Ltd. (DMF 26881), Zhejiang Shenzhou Pharmaceutical Co., Ltd. (DMF 20286), DASAMI LAB PRIVATE LTD (DMF 36678), HUBEI GOTO BIOTECHNOLOGY CO LTD (DMF 32370) and NORTEC QUIMICA SA (DMF 37708) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Spironolactone records mean?

8 organisations have only inactive Type II DMFs for Spironolactone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Spironolactone have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Spironolactone on the EDQM register, including ZHEJIANG SHENZHOU PHARMACEUTICAL CO., LTD. Taizhou (CN), TIANJIN JINJIN PHARMACEUTICAL CO., LTD. Xiqing District (CN), EUROAPI FRANCE Vertolaye (FR), G.D. Searle LLC New York (US), TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin (CN) and GEDEON RICHTER PLC. Budapest (HU) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Spironolactone?

Yes. The latest patent listed for an approved US product containing Spironolactone expires 28 Oct 2036, across 36 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Spironolactone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Spironolactone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.